Pediatric Ophthalmology
An Introduction to Paediatric Ophthalmology
Paediatric ophthalmology has made great strides over the past few decades. Advances in diagnostic techniques and treatments have helped overcome some of the challenges in examining younger patients and treatment advances in areas such as retinopathy of prematurity (ROP) have helped to improve visual outcomes.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
Two ARVO 2026 abstracts highlight the continuing shift in retinopathy of prematurity (ROP) care, with longer-term trial data supporting the durability of intravitreal aflibercept and real-world registry data showing increasing national adoption of anti-VEGF therapy. Together, the findings suggest that anti-VEGF therapy is becoming an increasingly important part of ROP management, while reinforcing the need for structured follow-up and continued training in both injection-based and laser approaches.
The first months of 2026 have already seen a number of interesting studies and reviews published across the ophthalmology literature, setting the stage for another year of progress in the field. Below, we highlight a selection of recent papers from major journals that we found particularly notable over the past few weeks.
In this Future Leaders interview, Dr Sethi reflects on the early inspirations that drew him to ophthalmology, the mentors who have shaped his approach to practice, and the innovations that most excite him today.
A recent study in Cell Reports reports that myopia may be associated not only with sensory retinal deficits but also with abnormal visuomotor responses during accommodation.
In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.
If you work in children’s eye care, mark your calendar for Friday, 12 September 2025. That’s when the World Society of Paediatric Ophthalmology and Strabismus (WSPOS) takes over Copenhagen with its annual Subspecialty Day, held in conjunction with the 43rd ESCRS Congress.
As the world marked 75 years since the first intraocular lens (IOL) implantation in November 2024, the World Society of Paediatric Ophthalmology and Strabismus (WSPOS) launched an important initiative to reflect on how far we’ve come and how much we still need to learn, especially in the paediatric space. While IOL technology has advanced significantly, there is still no global consensus on best practices for paediatric implantation. Clinical decisions vary widely based on age, laterality, surgical approach, available resources, and follow-up capability. This variability makes it difficult to benchmark outcomes or standardise care. That’s why WSPOS is conducting what we hope will be the largest-ever international survey on paediatric IOL implantation.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...
A pioneering gene therapy trial reported in The Lancet by Prof Michel Michaelides (UCL Institute of Ophthalmology and Moorfields Eye Hospital), Dr Yannik Laich and colleagues at Moorfields Eye Hospital and Great Ormond Street Hospital for Children (London, UK), has shown life-changing visual improvements in children with Leber Congenital Amaurosis type 4 (LCA4), a rare and severe inherited retinal dystrophy caused by mutations in the AIPL1 gene.1Â Â Infants with pathogenic variants in the AIPL1 gene experience severe and rapidly progressive vision loss starting at birth.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
This episode explores the inspiring work of Orbis International, a nonprofit preventing blindness and restoring sight in underserved communities. Dr Maria Berrocal, Associate Professor and Orbis Volunteer Faculty, shares her experience aboard the Orbis Flying Eye Hospital, a fully equipped surgical and teaching hospital on an aircraft, and discusses the importance of global collaboration in building sustainable, high-quality eye care systems around the world.
The International Congenital Corneal Opacification Network (ICCON) is a pioneering initiative dedicated to improving the care and management of children with congenital corneal opacities worldwide. Established by the World Society of Paediatric Ophthalmology and Strabismus (WSPOS) in collaboration with the Paediatric Keratoplasty Association (PKA), ICCON aims to connect specialists, surgeons, and healthcare professionals with a shared mission: ensuring that children with these rare yet challenging conditions receive the expertise and treatment they need.
In this Q&A, Dr Nguyen reflects on her career challenges, rewarding moments and what excites her about the future of ophthalmology.
In this Q&A, we celebrate Dr Chang’s accomplishments and gain insights into her vision for the future of paediatric neuro-ophthalmology.
The EURETINA 2024 Congress, held in Barcelona from September 19-22, brought together leading experts in ophthalmology to share the latest research and innovative treatments for retinal diseases. Among the highlights were several late-breaking abstracts that showcased promising advances in therapeutics for conditions such as retinopathy of prematurity (ROP), diabetic retinopathy (DR) and age-related macular degeneration (AMD). These studies not only demonstrated the efficacy and safety of novel treatment options but also addressed critical unmet needs in reducing patient burden and improving long-term outcomes.
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
